241 related articles for article (PubMed ID: 14688011)
1. inv(3)(q21q26) in AML/MDS: Monitoring of the malignant clone with interphase FISH.
Schmidt HH; Pirc-Danoewinata H; Linkesch W; Strunk D; Wieser R
Haematologica; 2003 Dec; 88(12):ECR38. PubMed ID: 14688011
[No Abstract] [Full Text] [Related]
2. Development of a dual-color, double fusion FISH assay to detect RPN1/EVI1 gene fusion associated with inv(3), t(3;3), and ins(3;3) in patients with myelodysplasia and acute myeloid leukemia.
Shearer BM; Sukov WR; Flynn HC; Knudson RA; Ketterling RP
Am J Hematol; 2010 Aug; 85(8):569-74. PubMed ID: 20556821
[TBL] [Abstract][Full Text] [Related]
3. Insufficient outcomes with imatinib mesylate: case report of Ph-positive acute myeloid leukemia evolving from myelodysplastic syndrome.
Isoda A; Nakahashi H; Hoshino T; Mitsui T; Yoshida Y
Am J Hematol; 2007 Jun; 82(6):501-2. PubMed ID: 17301971
[No Abstract] [Full Text] [Related]
4. [Myelodysplastic syndromes and acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2) abnormality].
Calderón-Cabrera C; Falantes JF; Bernal R; Pérez-Simón JA
Med Clin (Barc); 2015 Sep; 145(5):224-6. PubMed ID: 25190583
[No Abstract] [Full Text] [Related]
5. [WHO classification of acute myeloid leukaemia (AML) and the myelodysplastic syndrome (MDS)].
Haferlach T; Schoch C
Dtsch Med Wochenschr; 2002 Mar; 127(9):447-50. PubMed ID: 11870559
[No Abstract] [Full Text] [Related]
6. Acute minimally differentiated myeloid leukemia (M0) with inv(3)(q21q26).
Fujisawa S; Tanabe J; Harano H; Kanamori H; Motomura S; Mohri H; Ishigatsubo Y
Leuk Lymphoma; 1999 Nov; 35(5-6):627-30. PubMed ID: 10609803
[TBL] [Abstract][Full Text] [Related]
7. Clonality analysis of cell lineages in acute myeloid leukemia with inversion 16.
Chang H; Nayar R; Li D; Sutherland DR
Cancer Genet Cytogenet; 2005 Jan; 156(2):175-8. PubMed ID: 15642400
[TBL] [Abstract][Full Text] [Related]
8. Myelodysplastic syndrome with inv(3)(q21q26.2) or t(3;3)(q21;q26.2) has a high risk for progression to acute myeloid leukemia.
Cui W; Sun J; Cotta CV; Medeiros LJ; Lin P
Am J Clin Pathol; 2011 Aug; 136(2):282-8. PubMed ID: 21757602
[TBL] [Abstract][Full Text] [Related]
9. A case of atypical myelodysplastic syndrome with micromegakaryocytes, normal platelet count, and t(3;12)(q21;p13) with inv(3)(q21q26).
Schnittger S; Schoch C; Streubel B; Hinrichs HF; Otremba B; Parwaresch R; Fonatsch C
Genes Chromosomes Cancer; 1997 Nov; 20(3):292-8. PubMed ID: 9365837
[TBL] [Abstract][Full Text] [Related]
10. Translocation (3;8)(q26;q24): a recurrent chromosomal abnormality in myelodysplastic syndrome and acute myeloid leukemia.
Lin P; Medeiros LJ; Yin CC; Abruzzo LV
Cancer Genet Cytogenet; 2006 Apr; 166(1):82-5. PubMed ID: 16616115
[TBL] [Abstract][Full Text] [Related]
11. Deletion of sequences telomeric of the EVI1 gene in 3q26 associated with a novel pericentric inv(3)(p25q26) in a patient with acute myelogenous leukemia.
Wieser R; Lechner K; Valent P; Fonatsch C
Haematologica; 2003 Dec; 88(12):1427-9. PubMed ID: 14688000
[No Abstract] [Full Text] [Related]
12. [Essential thrombocythemia in transformation from myelodysplastic syndrome to acute myeloid leukemia with inv(3) after treatment for gastric cancer].
Horikoshi M; Machida U; Itikawa M; Seo S; Masuda S; Kurokawa M; Ogawa S; Sunaga S; Honda H; Aoki K; Chiba S; Mitani K; Hirai H; Yazaki Y
Rinsho Ketsueki; 2000 Jan; 41(1):68-71. PubMed ID: 10695403
[TBL] [Abstract][Full Text] [Related]
13. Inversion of chromosome 11 inv(11)(p15q22), as a recurring chromosomal aberration associated with de novo and secondary myeloid malignancies: identification of a P1 clone spanning the 11q22 breakpoint.
Kobayashi H; Arai Y; Hosoda F; Maseki N; Hayashi Y; Eguchi H; Ohki M; Kaneko Y
Genes Chromosomes Cancer; 1997 Jul; 19(3):150-5. PubMed ID: 9218995
[TBL] [Abstract][Full Text] [Related]
14. Masked inv(3)(q21q26) in a patient with minimally differentiated acute myeloid leukemia.
Wieser R; Schreiner U; Wollenberg B; Neubauer A; Fonatsch C; Rieder H
Haematologica; 2001 Feb; 86(2):214-5. PubMed ID: 11224497
[No Abstract] [Full Text] [Related]
15. Complex or monosomal karyotype and not blast percentage is associated with poor survival in acute myeloid leukemia and myelodysplastic syndrome patients with inv(3)(q21q26.2)/t(3;3)(q21;q26.2): a Bone Marrow Pathology Group study.
Rogers HJ; Vardiman JW; Anastasi J; Raca G; Savage NM; Cherry AM; Arber D; Moore E; Morrissette JJ; Bagg A; Liu YC; Mathew S; Orazi A; Lin P; Wang SA; Bueso-Ramos CE; Foucar K; Hasserjian RP; Tiu RV; Karafa M; Hsi ED
Haematologica; 2014 May; 99(5):821-9. PubMed ID: 24463215
[TBL] [Abstract][Full Text] [Related]
16. Molecular heterogeneity in AML/MDS patients with 3q21q26 rearrangements.
Lahortiga I; Vázquez I; Agirre X; Larrayoz MJ; Vizmanos JL; Gozzetti A; Calasanz MJ; Odero MD
Genes Chromosomes Cancer; 2004 Jul; 40(3):179-89. PubMed ID: 15138998
[TBL] [Abstract][Full Text] [Related]
17. Fluorescence in situ hybridization analysis of 110 hematopoietic disorders with chromosome 5 abnormalities: do de novo and therapy-related myelodysplastic syndrome-acute myeloid leukemia actually differ?
Lessard M; Hélias C; Struski S; Perrusson N; Uettwiller F; Mozziconacci MJ; Lafage-Pochitaloff M; Dastugue N; Terré C; Brizard F; Cornillet-Lefebvre P; Mugneret F; Barin C; Herry A; Luquet I; Desangles F; Michaux L; Verellen-Dumoulin C; Perrot C; Van den Akker J; Lespinasse J; Eclache V; Berger R;
Cancer Genet Cytogenet; 2007 Jul; 176(1):1-21. PubMed ID: 17574959
[TBL] [Abstract][Full Text] [Related]
18. Polysomy 8 defines a clinico-cytogenetic entity representing a subset of myeloid hematologic malignancies associated with a poor prognosis: report on a cohort of 12 patients and review of 105 published cases.
Beyer V; Mühlematter D; Parlier V; Cabrol C; Bougeon-Mamin S; Solenthaler M; Tobler A; Pugin P; Gregor M; Hitz F; Hess U; Chapuis B; Laurencet F; Schanz U; Schmidt PM; van Melle G; Jotterand M
Cancer Genet Cytogenet; 2005 Jul; 160(2):97-119. PubMed ID: 15993266
[TBL] [Abstract][Full Text] [Related]
19. [Detection of inv (16) in acute myelomonocytic leukemia by interphase fluorescence in situ hybridization].
Li J; Pan J; Wu Y; Guo Y; Xue Y
Zhonghua Xue Ye Xue Za Zhi; 2002 Jan; 23(1):30-2. PubMed ID: 12015086
[TBL] [Abstract][Full Text] [Related]
20. Interphase fluorescence in situ hybridization assay for the detection of 3q21 rearrangements in myeloid malignancies.
Wieser R; Schreiner U; Pirc-Danoewinata H; Aytekin M; Schmidt HH; Rieder H; Fonatsch C
Genes Chromosomes Cancer; 2001 Dec; 32(4):373-80. PubMed ID: 11746978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
